8 news items
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
TEVA
1 Jun 24
Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
TEVA
1 Jun 24
.
About Tardive Dyskinesia (TD)
Tardive dyskinesia (TD) is a highly debilitating, chronic
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
TEVA
29 May 24
and HD chorea treat these chronic, involuntary movements," said Dell Faulkingham, Senior Vice President, Head of U.S. Innovative Medicines at Teva
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
ALVO
TEVA
20 May 24
.
Plaque Psoriasis (Ps): The treatment of adult patients with moderate to severe chronic Ps who are candidates
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
TEVA
8 May 24
million people are currently diagnosed with schizophrenia in the U.S. It is a chronic, progressive, and severely debilitating mental disorder
hbted2wwirw82lr5q16rov4h92sgdozlutsbey p67uzw
TEVA
11 Apr 24
or chronic migraine vs placebo. The study enrolled 365 patients who were randomized to receive a subcutaneous injection of fremanezumab once-monthly
bsj6y3f txv6fay6ev
TEVA
6 Apr 24
Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels
ho9wqwqh dto
AZN
GSK
TEVA
21 Mar 24
per month for all its asthma and chronic obstructive pulmonary disease (COPD) medicines.
The program will be implemented by January 1, 2025
- Prev
- 1
- Next